Allogeneic T cell progenitors, cultured ex-vivo Clinical Trials
2 recruitingBiologic
Phase 12Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide
Hematological Malignancies
Smart Immune SAS40 enrolled4 locationsNCT05768035
Recruiting
Phase 1Phase 2
Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT
Hematological Malignancies
Smart Immune SAS36 enrolled1 locationNCT04959903